This website uses cookies to help us give you the best experience when you visit our website. By continuing to use this website, you consent to our use of these cookies.

Find out more about how we use cookies and how to manage them by reading our cookie notice.

Flavia Borellini

GPVP for AZD9291

She has over 15 years of experience in management positions in the biopharmaceutical/biotechnology industry, including global management of drug development lifecycle, from pre-clinical to on-market stage, and extensive experience in drug/diagnostic co-development and personalized healthcare in oncology. As Life Cycle Leader, Zelboraf (vemurafenib) for Roche Genentech, she delivered the first FDA approval in circa 5 years from first time in man, a record on its own, doubled by the first ever concurrent US approval of a drug and its companion diagnostic (a cobas 4800 BRAF Mutation Test).

You are viewing: All posts Reset filters

Our Other Authors